" class="no-js "lang="en-US"> Ross Upton - Medtech Alert
Tuesday, July 22, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Ross Upton

Ross Upton

About Ross Upton

Ross Upton is the founder and CEO of Ultromics, a University of Oxford spin-out technology company that has built an AI-based platform to predict patient outcomes in the field of cardiovascular imaging.

The “EchoGo” platform is designed to improve both clinical outcomes in patients and save billions for healthcare systems worldwide.

Ross has a broad scientific background having undertaken 4 degrees in the clinical sciences. During the last 3 years, he has built Ultromics to be one of the most prominent companies in healthcare AI, leading the creation of EchoGo which has received FDA clearance and qualified for reimbursement.

Ross has successfully raised multiple rounds of funding and was named on the 2019 Forbes 30 under 30 lists for science and healthcare.

Related Story

Artificial Intelligence

 Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands | Pharmtech Focus

Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands

November 9 2021

Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]

Artificial Intelligence

 Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment | Pharmtech Focus

Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment

August 17 2021

Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]